V
Virginia L. Gill
Publications - 2
Citations - 222
Virginia L. Gill is an academic researcher. The author has contributed to research in topics: Toceranib & Maintenance therapy. The author has an hindex of 2, co-authored 2 publications receiving 187 citations.
Papers
More filters
Journal ArticleDOI
Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours
Cheryl A. London,Tamra Mathie,Nicole Stingle,Craig A. Clifford,Siobhan Haney,Mary K. Klein,Linda Beaver,Kate Vickery,David M. Vail,Betsey Hershey,Susan Ettinger,Andrew Vaughan,Francisco J. Alvarez,Lorin Hillman,Mike Kiselow,Doug H. Thamm,Mary Lynn Higginbotham,Meredith Gauthier,Erika L. Krick,Brenda Phillips,Tracy Ladue,Pam Jones,Jeffery Bryan,Virginia L. Gill,Andrew Novasad,Lisa Fulton,Janet K. Carreras,C. J. McNeill,Carolyn J. Henry,Sarah Gillings +29 more
TL;DR: Preliminary evidence that toceranib exhibits CB in dogs with certain solid tumours is provided, although future prospective studies are necessary to define its true activity.
Journal ArticleDOI
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study
Cheryl A. London,Heather L. Gardner,Tamra Mathie,Nicole Stingle,Roberta Portela,Michael L. Pennell,Craig A. Clifford,Mona P. Rosenberg,David M. Vail,Laurel E. Williams,Kim L. Cronin,Heather Wilson-Robles,Antonella Borgatti,Carolyn J. Henry,Dennis B. Bailey,Jennifer Locke,Nicole C. Northrup,Martin Crawford-Jakubiak,Virginia L. Gill,Mary K. Klein,David M. Ruslander,Doug H. Thamm,Brenda Phillips,G. S. Post +23 more
TL;DR: The addition of toceranib to metronomic piroxicam/cyclophosphamide therapy following amputation and carboplatin chemotherapy did not improve median DFI, OS or the 1-year survival rate in dogs with OSA.